| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Hepatitis - B
|
NIDDK
|
5F32DK074348-02
|
|
Hepatoxicity in an African HIV Treatment Cohort
|
HOFFMANN, CHRISTOPHER
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$53,992
|
|
Hepatitis - B
|
NCI
|
5R01CA040489-23
|
|
Pathogenesis of Hepatitis B Virus in Transgenic Mice
|
CHISARI, FRANCIS
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$792,726
|
|
Hepatitis - B
|
NIAID
|
2R01AI020001-25
|
|
Pathogenesis of Liver Disease in Hepatitis
|
CHISARI, FRANCIS
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$685,357
|
|
Hepatitis - B
|
NIAID
|
5R01AI064844-03
|
|
Role of Hepatitis B virus X protein in HBV replication.
|
BOUCHARD, MICHAEL
|
DREXEL UNIVERSITY
|
PA
|
$315,019
|
|
Hepatitis - B
|
NIAID
|
5R01AI067417-03
|
|
Molecular Modulation of HBV Capsid Assembly
|
ZLOTNICK, ADAM
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$345,885
|
|
Hepatitis - B
|
NIAID
|
5R01AI026522-30
|
|
Structure and Replication of Hepatitis Delta Virus
|
TAYLOR, JOHN
|
INSTITUTE FOR CANCER RESEARCH
|
PA
|
$632,726
|
|
Hepatitis - B
|
NIAID
|
5R01AI020720-25
|
|
Mechanisms of Chronic Hepatitis B Infection and Therapeutic Vaccines
|
MILICH, DAVID
|
VACCINE RESEARCH INSTITUTE OF SAN DIEGO
|
CA
|
$747,395
|
|
Hepatitis - B
|
NIAID
|
5R01AI043453-11
|
|
Mechanisms of Hepadnavirus Assembly and Replication
|
HU, JIANMING
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$297,279
|
|
Hepatitis - B
|
NIAID
|
5R01AI030070-16
|
|
Regulation of Hepatitis B Virus Transcription
|
MCLACHLAN, ALAN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$512,408
|
|
Hepatitis - B
|
NCI
|
5R01CA023931-30
|
|
Analyzing Hepatitis B Virus Pathogenesis
|
ISOM, HARRIET
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$325,985
|
|
Hepatitis - B
|
NIAID
|
5U01AI064002-04
|
|
Chemoprophylaxis for HIV Prevention in Men
|
GRANT, ROBERT
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$5,141,967
|
|
Hepatitis - B
|
NCI
|
5R01CA056533-16
|
|
Viral and Cellular Determinants of Hepatitis B Virus Pathogenesis
|
SCHNEIDER, ROBERT
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$423,021
|
|
Hepatitis - B
|
NIAID
|
5R01AI060018-04
|
|
Mechanisms of Avian Hepadnavirus Replication
|
LOEB, DANIEL
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$332,989
|
|
Hepatitis - B
|
NCI
|
5R01CA109733-04
|
|
Molecular Target(s) for Interruption of HBV Infection
|
LI, JISU
|
RHODE ISLAND HOSPITAL (PROVIDENCE, RI)
|
RI
|
$214,052
|
|
Hepatitis - B
|
NIAID
|
5R21AI067455-02
|
|
Resolution of Acute Hepatitis B Virus Infections in Chimpanzees
|
LANFORD, ROBERT
|
SOUTHWEST FOUNDATION FOR BIOMEDICAL RES
|
TX
|
$222,579
|
|
Hepatitis - B
|
NIAID
|
5R01AI068090-03
|
|
Understanding Immunopathogenesis of Hepatitis B Virus
|
BARON, JODY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$367,527
|
|
Hepatitis - B
|
NIAID
|
5R01AI018641-26
|
|
Hepadnavirus Infections and Liver Cancer
|
MASON, WILLIAM
|
INSTITUTE FOR CANCER RESEARCH
|
PA
|
$562,151
|
|
Hepatitis - B
|
NIAID
|
5R01AI073299-02
|
|
Mechanism and in vivo anti-HBV study of a novel class of non-nucleoside compounds
|
CHENG, YUNG-CHI
|
YALE UNIVERSITY
|
CT
|
$365,024
|
|
Hepatitis - B
|
NCI
|
1R21CA127046-01A1
|
|
Analysis of the Cytokine-Immunological Model of a Cancer-Related Symptom Cluster
|
STEEL, JENNIFER
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$204,525
|
|
Hepatitis - B
|
NIDDK
|
1R01DK078686-01A1
|
|
Genetic and epigenetic regulation of Hepatitis B contributes to liver cancer
|
TORBENSON, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$348,500
|
|
Hepatitis - B
|
NCI
|
5R01CA112053-04
|
|
Mechanisms of the HBX-interacting protein (HBXIP)
|
REED, JOHN
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
CA
|
$357,678
|
|
Hepatitis - B
|
NIAID
|
1R43AI068239-01A1
|
|
An Orally Delivered Hepatitis B Vaccine
|
HOWARD, JOHN
|
APPLIED BIOTECHNOLOGY INSTITUTE
|
CA
|
$295,171
|
|
Hepatitis - B
|
NCI
|
5R01CA055578-13
|
|
Role of PreS2 Mutants in Pathogenesis of Chronic Hepatitis B
|
YEN, TIEN-SZE
|
NORTHERN CALIFORNIA INSTITUTE RES & EDUC
|
CA
|
$245,449
|
|
Hepatitis - B
|
NIAID
|
5R01AI057504-04
|
|
Regulatory mechanisms of HBV X gene Transcription
|
TAKADA, SHINAKO
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$316,025
|
|
Hepatitis - B
|
NCI
|
1R41CA132397-01
|
|
Small Molecule Inhibitors of HBV/HCV Induced Liver Diseases
|
DHEER, SURENDRA
|
SONITU PHARMACEUTICALS, LLC
|
PA
|
$168,000
|
|
Hepatitis - B
|
NCI
|
5R03CA128048-02
|
|
Development of a vaccine against Helicobacter pylori to prevent gastric cancer
|
BEGUE, RODOLFO
|
CHILDREN'S HOSPITAL (NEW ORLEANS)
|
LA
|
$77,950
|
|
Hepatitis - B
|
NIAID
|
5R01AI068885-02
|
|
Novel Therapeutic Approaches for Eliminating Hepatitis B Virus DNAs and RNAs
|
MCCAFFREY, ANTON
|
UNIVERSITY OF IOWA
|
IA
|
$361,744
|
|
Hepatitis - B
|
NCI
|
5R01CA037232-24
|
|
HEPADNAVIRUS ASSOCIATED HEPATOCELLULAR CARCINOMA
|
ROGLER, CHARLES
|
YESHIVA UNIVERSITY
|
NY
|
$483,550
|
|
Hepatitis - B
|
NICHD
|
5U01HD040470-08
|
|
New Orleans Adolescent Medicine Trials Unit
|
ABDALIAN, SUE
|
TULANE UNIVERSITY OF LOUISIANA
|
LA
|
$581,030
|
|
Hepatitis - B
|
NCI
|
5R01CA067529-14
|
|
Helicobacter induced hepatitis and tumorigenesis
|
FOX, JAMES
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$341,346
|
|
Hepatitis - B
|
NIAID
|
5R01AI060449-05
|
|
Liver Disease and HIV-HBV Coinfection in the HAART era
|
THIO, CHLOE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$587,069
|
|
Hepatitis - B
|
NCI
|
5R01CA111427-05
|
|
Early antibody markers of HCC
|
FEITELSON, MARK
|
TEMPLE UNIVERSITY
|
PA
|
$276,457
|
|
Hepatitis - B
|
NCI
|
5R01CA113663-04
|
|
Hepatitis B ESL Education for Chinese
|
TAYLOR, VICTORIA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$400,747
|
|
Hepatitis - B
|
NIAID
|
5R37AI041980-12
|
|
NUCLEOSIDES WITH DUAL ANTI-HIV AND HBV ACTIVITY
|
SCHINAZI, RAYMOND
|
EMORY UNIVERSITY
|
GA
|
$210,146
|
|
Hepatitis - B
|
NCI
|
1R25CA129042-01A1
|
|
Asian American Liver Cancer Education Program in Maryland
|
JUON, HEE-SOON
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$276,609
|
|
Hepatitis - B
|
NCRR
|
5R01RR006555-17
|
|
Modeling Viral and T Lymphocyte Dynamics
|
PERELSON, ALAN
|
LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB
|
NM
|
$307,697
|
|
Hepatitis - B
|
NICHD
|
1P01HD057247-01
|
0003
|
Molecular Characterization of Liver Gene Transfer and Its Oncogenic Potential
|
GAO, GUANG-PING%
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$122,883
|
|
Hepatitis - B
|
NIEHS
|
5R01ES005116-18
|
|
Biological Markers of Aflatoxin Exposure
|
SANTELLA, REGINA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$337,642
|
|
Hepatitis - B
|
NCI
|
5R01CA122295-02
|
|
Androgen Receptor Roles in Liver Cancer Incidence and Progression
|
CHANG, CHAWNSHANG
|
UNIVERSITY OF ROCHESTER
|
NY
|
$292,600
|
|
Hepatitis - B
|
NIAID
|
5R01AI071068-03
|
|
RNAi for the Treatment of Viral Hepatitis
|
KAY, MARK
|
STANFORD UNIVERSITY
|
CA
|
$377,376
|
|
Hepatitis - B
|
NIAID
|
5U01AI066735-04
|
|
Partnership for developing broad-spectrum microbicides
|
PHILLIPS, DAVID
|
POPULATION COUNCIL
|
NY
|
$468,242
|
|
Hepatitis - B
|
NIAID
|
2R01AI040696-11A2
|
|
Regulation of HBV Replication by the Immune System
|
GUIDOTTI, LUCA
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$473,750
|
|
Hepatitis - B
|
NCI
|
5R01CA120206-03
|
|
Identification of Altered Glycan and Glycoproteins in Viral Induced Liver Cancer
|
MEHTA, ANAND
|
DREXEL UNIVERSITY
|
PA
|
$317,565
|
|
Hepatitis - B
|
NCI
|
5R13CA095919-07
|
|
Workshops on Viral Pathogenesis and Oncogenesis
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$9,000
|
|
Hepatitis - B
|
NIAID
|
1R01AI074982-01A1
|
|
Molecular Mechanism of Hepadnavirus Persistence
|
HU, JIANMING
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$300,541
|
|
Hepatitis - B
|
NCI
|
2P01CA022443-31
|
0011
|
Mechanisms of Hepatitis B Virus Replication
|
LOEB, DANIEL
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$240,843
|
|
Hepatitis - B
|
NCI
|
2P01CA022443-31
|
9003
|
Instrumentation
|
LOEB, DANIEL
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$56,901
|
|
Hepatitis - B
|
NCI
|
1R21CA133976-01A2
|
|
Hepatitis B virus immune escape mutants
|
TONG, SHUPING
|
RHODE ISLAND HOSPITAL (PROVIDENCE, RI)
|
RI
|
$145,789
|
|
Hepatitis - B
|
NIAID
|
1R21AI073928-01A2
|
|
Development of a plant-derived virus-like particle vaccine against SARS-CoV
|
HUANG, ZHONG
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$187,701
|
|
Hepatitis - B
|
NINR
|
5K23NR010408-02
|
|
The Psychoneuroimmunology of Insomnia: Response to a Vaccine Challenge
|
PIGEON, WILFRED
|
UNIVERSITY OF ROCHESTER
|
NY
|
$129,951
|
|
Hepatitis - B
|
NIAID
|
5R01AI049730-08
|
|
DEVELOPMENT OF THE HBcAG AS A VACCINE CARRIER PLATFORM
|
MILICH, DAVID
|
VACCINE RESEARCH INSTITUTE OF SAN DIEGO
|
CA
|
$531,825
|
|
Hepatitis - B
|
NIDA
|
5R01DA003018-26
|
|
Pulmonary and Immunologic Effects of Marijuana Use on HIV and Viral Immunity
|
ROTH, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$564,473
|
|
Hepatitis - B
|
NIEHS
|
5R01ES014662-02
|
|
Serum Organochlorine Levels and Primary Liver Cancer: A Nested Case-Control Study
|
ENGEL, LAWRENCE
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$763,744
|
|
Hepatitis - B
|
NIAID
|
5R43AI068566-02
|
|
Novel gp41 Immunogens for HIV-1 Vaccines
|
WHALEN, ROBERT
|
MAXYGEN, INC.
|
CA
|
$298,727
|
|
Hepatitis - B
|
NIEHS
|
5R21ES015954-02
|
|
Activating liver carcinogens in yeast by expressing CYP450 polymorphisms
|
FASULLO, MICHAEL
|
ORDWAY RESEARCH INSTITUTE, INC.
|
NY
|
$217,438
|
|
Hepatitis - B
|
NCI
|
1R43CA133993-01
|
|
Immune Response Modification for Treatment of Hepatocellular Carcinoma
|
FAIRMAN, JEFF
|
JUVARIS BIOTHERAPEUTICS, INC.
|
CA
|
$255,467
|
|
Hepatitis - B
|
NIAID
|
5R21AI077012-02
|
|
Novel Molecules that Define Viral Persistence
|
BROOKS, DAVID
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$34,254
|
|
Hepatitis - B
|
NIAID
|
1R43AI077123-01A1
|
|
Novel HBV Therapeutic with Potential for Treatment of Drug-Resistant Infection
|
CUCONATI, ANDREA
|
PHARMABRIDGE, INC.
|
PA
|
$240,146
|
|
Hepatitis - B
|
NCI
|
5R01CA100579-04
|
|
Protein Kinase Pathways in Cytokine-Signaling
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY
|
IL
|
$250,281
|
|
Hepatitis - B
|
NCRR
|
5R21RR024229-02
|
|
New mouse model of hepatitis B virus-associated hepatocellular carcinoma
|
YEN, TIEN-SZE
|
NORTHERN CALIFORNIA INSTITUTE RES & EDUC
|
CA
|
$193,060
|
|
Hepatitis - B
|
NIAID
|
1R13AI078719-01
|
|
2008 International Meeting: The Molecular Biology of Hepatitis B Viruses
|
WIELAND, STEFAN
|
HEPATITIS B FOUNDATION
|
PA
|
$15,000
|
|
Hepatitis - B
|
NIDDK
|
5R01DK078424-03
|
|
Studies on RNAi Based Delivery in Vivo
|
KAY, MARK
|
STANFORD UNIVERSITY
|
CA
|
$318,992
|
|
Hepatitis - B
|
NCI
|
5R01CA123544-02
|
|
Biomarker for Hepatocellular Carcinoma
|
WANDS, JACK
|
RHODE ISLAND HOSPITAL (PROVIDENCE, RI)
|
RI
|
$237,762
|
|
Hepatitis - B
|
NIAID
|
5R01AI071820-03
|
|
Hepatitis B treatment and HIV Infection in resources limited settings
|
THIO, CHLOE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$392,200
|
|
Hepatitis - B
|
NIAAA
|
5F31AA016865-02
|
|
Hepatitis B Virus X Protein and Alcohol Regulation of Mitochondria and Apoptosis
|
CLIPPINGER, AMY
|
DREXEL UNIVERSITY
|
PA
|
$29,172
|
|
Hepatitis - B
|
NCI
|
5R01CA129763-02
|
|
A Randomized Trial of Hep B Screening and Vaccination in High Risk Vietnamese
|
MA, GRACE
|
TEMPLE UNIVERSITY
|
PA
|
$479,743
|
|
Hepatitis - B
|
NCI
|
5F31CA119941-03
|
|
Hepatitis B virus (HBV)-Viral Particle Assembly
|
KONKIN, TAMAKO
|
BROWN UNIVERSITY
|
RI
|
$26,554
|
|
Hepatitis - B
|
NIAID
|
5R43AI072842-02
|
|
Liquid Crystal Diagnostic for Multiplex Hepatitis Screening
|
WILLIAMS, JEFFREY
|
PLATYPUS TECHNOLOGIES, LLC
|
WI
|
$299,978
|
|
Hepatitis - B
|
NCMHD
|
1R24MD002756-01
|
|
CBPR on Hepatitis B Intervention for Underserved Korean Americans
|
MA, GRACE
|
TEMPLE UNIVERSITY
|
PA
|
$528,453
|
|
Hepatitis - B
|
NIGMS
|
5R01GM062357-07
|
|
U-turn of the Hepatitis Delta Virus Ribozyme
|
WALTER, NILS
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$268,797
|
|
Hepatitis - B
|
OD
|
1R01CA134245-01
|
|
Evaluation of a Hepatitis B Outreach Intervention for Cambodians
|
TAYLOR, VICTORIA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$424,370
|
|
Hepatitis - B
|
NIAID
|
1K23AI066983-01A2
|
|
HIV and Hepatitis B Coinfection: Hepatitis B Genotype, Resistance and Outcomes
|
BHATTACHARYA, DEBIKA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$123,390
|
|
Hepatitis - B
|
NCI
|
5R01CA129096-02
|
|
Statewide Communication to Reach Diverse Low Income Women
|
PASICK, RENA
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$317,990
|
|
Hepatitis - B
|
NCI
|
5R01CA074131-12
|
|
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA
|
FAUSTO, NELSON
|
UNIVERSITY OF WASHINGTON
|
WA
|
$280,617
|
|
Hepatitis - B
|
NIEHS
|
2P01ES006052-15A1
|
0005
|
RESEARCH PROJECT 1: Chemical and Viral Biomarkers of Exposure and Risk (Groopman)
|
GROOPMAN, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$409,002
|
|
Hepatitis - B
|
NIEHS
|
2P01ES006052-15A1
|
9002
|
CORE A: Biostatistics/Epidemiology
|
MUNOZ, ALVARO
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$100,476
|
|
Hepatitis - B
|
NCI
|
1R01CA131133-01A1
|
|
Viral Vaccine Vectors to Prevent Hepatocellular Carcinoma
|
ROBEK, MICHAEL
|
YALE UNIVERSITY
|
CT
|
$274,730
|
|
Hepatitis - B
|
NIAID
|
1R01AI076535-01A1
|
|
Combination therapies for chronic HBV, liver disease and cancer
|
FEITELSON, MARK
|
TEMPLE UNIVERSITY
|
PA
|
$366,600
|
|
Hepatitis - B
|
NHLBI
|
2R44HL083553-02
|
|
Plant-Derived hepatitis B Vaccine from Biomanufacturing System to Clinical Trial
|
BRITT, ROBERT
|
QUANTUM TUBERS CORPORATION
|
WI
|
$633,112
|
|
Hepatitis - B
|
NIAID
|
1R43AI078638-01A1
|
|
Calcium phosphate-interferon (CaP-IFN) particles for pulmonary delivery of IFN
|
MORCOL, TULIN
|
BIOSANTE PHARMACEUTICALS, INC
|
IL
|
$142,250
|
|
Hepatitis - B
|
NHLBI
|
2R44HL071494-04
|
|
DRW HIV-Ab/HBsAg Duplex Rapid Test submission for FDA-PMA approval
|
LEE, HELEN
|
DIAGNOSTICS FOR THE REAL WORLD, LTD
|
CA
|
$1,762,981
|
|
Hepatitis - B
|
NIAAA
|
1F31AA017811-01
|
|
Hepatitis B Virus X protein and Alcohol Regulation of Cell Cycle Progression
|
GEARHART, TRICIA
|
DREXEL UNIVERSITY
|
PA
|
$27,255
|
|
Hepatitis - B
|
NIDDK
|
1U01DK082843-01
|
|
Optimal Long-term Outcome of Chronic Hepatitis B
|
KIM, W. RAY
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$157,025
|
|
Hepatitis - B
|
NIDDK
|
1U01DK082874-01
|
|
Durability of HBV DNA Suppression in Cirrhotics After Stopping Therapy
|
HEATHCOTE, E
|
UNIVERSITY HEALTH NETWORK
|
CANADA
|
$101,548
|
|
Hepatitis - B
|
NIDDK
|
1U01DK082872-01
|
|
North Texas Hepatitis B Consortium: Clinical Site for the Hepatitis B Network
|
LEE, WILLIAM
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$161,935
|
|
Hepatitis - B
|
NIDDK
|
1U01DK082871-01
|
|
Midwest Hepatitis B Consortium
|
DI BISCEGLIE, ADRIAN
|
SAINT LOUIS UNIVERSITY
|
MO
|
$137,744
|
|
Hepatitis - B
|
NIDDK
|
1U01DK082867-01
|
|
The North Carolina Hepatitis Beta Clinical Research Network
|
FRIED, MICHAEL
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$149,081
|
|
Hepatitis - B
|
NIDDK
|
1U01DK082943-01
|
|
Hepatities Beta Research Network Clinical Center in Pacific Northwest/Alaska
|
CARITHERS, ROBERT
|
UNIVERSITY OF WASHINGTON
|
WA
|
$154,507
|
|
Hepatitis - B
|
NIDDK
|
1U01DK082863-01
|
|
Hepatitis B Clinical Research Network Clinical Center: Michigan-Hawaii consortium
|
LOK, ANNA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$143,168
|
|
Hepatitis - B
|
NIDDK
|
1U01DK082866-01
|
|
Immune regulation and co-stimulation in treatment outcome of chronic hepatitis B
|
CHANG, KYONG-MI
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$86,247
|
|
Hepatitis - B
|
NIDDK
|
1U01DK082864-01
|
|
Hepatitis B Clinical Research Network - Data Coordinating Center
|
BELLE, STEVEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$1,270,688
|
|
Hepatitis - B
|
NIDDK
|
1U01DK082919-01
|
|
Harvard Hepatitis B Consortium
|
LAU, DARYL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$129,767
|
|
Hepatitis - B
|
NIDDK
|
1U01DK082944-01
|
|
Defining Natural History and Optimal Treatment Outcome for Chronic HBV Infection
|
TERRAULT, NORAH
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$149,154
|
|
Hepatitis - B
|
NIDDK
|
1U01DK082923-01
|
|
Hepatitis B Clinical Research Network
|
SHIFFMAN, MITCHELL
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$119,209
|
|
Hepatitis - B
|
NIDDK
|
1U01DK082916-01
|
|
Effect of HBV DNA Methylation and the Mutant 1762T/1764A on Viral Load and HCC
|
SCHWARZ, KATHLEEN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$91,495
|
|
Hepatitis - B
|
NIDDK
|
1U01DK082927-01
|
|
HBV Research Network Database Protocol and Clinical Trial Study Proposals
|
HAN, STEVEN-HUY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$144,242
|
|
Hepatitis - B
|
NCI
|
3D43TW000010-21S2
|
|
Training in HIV Associated Malignacies, Rakai, Uganda
|
BEYRER, CHRIS
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$145,941
|
|
Hepatitis - B
|
NCI
|
3U54CA126513-02S1
|
|
The Role of Inflammation and Stroma in Digestive Cancer
|
WANG, TIMOTHY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$29,953
|
|
Hepatitis - B
|
NCI
|
5P01CA123328-02
|
0001
|
TRANSGENIC MICE AS A MODEL FOR HBV REPLICATION AND ONCOGENESIS
|
OU, J.-H. JAMES
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$293,727
|
|
Hepatitis - B
|
FIC
|
7K01TW007408-04
|
|
Blood-borne infection screening in an Afghan antenatal population
|
TODD, CATHERINE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$103,919
|
|
Hepatitis - B
|
NCMHD
|
5P60MD000538-06
|
0004
|
Hepatitis B infection & hepatocellular carcinoma in Asian Americans
|
POLLACK, HENRY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$503,316
|
|
Hepatitis - B
|
NCMHD
|
5P60MD000538-06
|
9004
|
RESEARCH CORE
|
TRINH-SHEVRIN, CHAU
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$667,376
|
|
Hepatitis - B
|
NIAID
|
1R56AI066024-01A2
|
|
Screen for an unexploited step in the HBV life cycle
|
CUCONATI, ANDREA
|
INSTITUTE FOR HEPATITIS & VIRUS RESEARCH
|
PA
|
$337,500
|
|
Hepatitis - B
|
NIAID
|
N01AI05399-15-0-1
|
|
Hepatitis Animal Models
|
NO PI IDENTIFIED
|
CORNELL UNIVERSITY ITHACA
|
NY
|
$2,256,885
|
|
Hepatitis - B
|
NIAID
|
5U19AI065412-03
|
0003
|
P3 - Effect of ZCM microbicide on HIV, HSV-2, HBV, C. trachomatis & T. Vaginalis
|
PHILLIPS, DAVID
|
POPULATION COUNCIL
|
NY
|
$249,890
|
|
Hepatitis - B
|
NIAID
|
5U19AI062150-05
|
0002
|
Mucosally Targeted Plant Based STI Vaccine
|
MASON, HUGH
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$349,576
|
|
Hepatitis - B
|
NIAID
|
5U19AI062150-05
|
0003
|
Plant Based Microbicides and Vaccines to Prevent STIs
|
TACKET, CAROL
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$324,356
|
|
Hepatitis - B
|
NIAID
|
7R21AI077012-03
|
|
Novel Molecules that Define Viral Persistence
|
BROOKS, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$203,163
|
|
Hepatitis - B
|
NIAID
|
5U19AI066332-04
|
0002
|
Plant-Based Production of Non-Envelope Antigens of HCV
|
ARNTZEN, CHARLES
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$272,474
|
|
Hepatitis - B
|
NIAID
|
7F31AI077323-02
|
|
Allostery in Hepatitis B Virus Capsid Assembly
|
KATEN, SARAH
|
INDIANA UNIVERSITY BLOOMINGTON
|
IN
|
$30,068
|
|
Hepatitis - B
|
NCI
|
5P01CA109091-03
|
0001
|
Promoting Hepatitis B Screening for Vietnamese American Adults
|
NGUYEN, TUNG
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$447,678
|
|
Hepatitis - B
|
NCI
|
5P01CA109091-03
|
0002
|
Community-based Hep B Intervention for Hmong Adults
|
CHEN, MOON
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$399,991
|
|
Hepatitis - B
|
NCI
|
5P01CA109091-03
|
0003
|
Increasing Hep B screening among Korean church attendees
|
BASTANI, ROSHAN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$523,130
|
|
Hepatitis - B
|
NCI
|
5P01CA109091-03
|
9002
|
Methodology Core
|
MAXWELL, ANNETTE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$115,357
|
|
Hepatitis - B
|
NCMHD
|
Y1MD8108-1-0-1
|
|
Hepatitis B Initiative
|
NO PI IDENTIFIED
|
|
|
$300,000
|
|
Hepatitis - B
|
NCMHD
|
Y1MD8116-1-0-1
|
|
REACH US
|
NO PI IDENTIFIED
|
|
|
$1,000,000
|
|
Hepatitis - B
|
NCRR
|
3G12RR008124-15S1
|
5558
|
CELL CULTURE CORE FACILITY
|
AGUILERA, RENATO
|
UNIVERSITY OF TEXAS EL PASO
|
TX
|
$43,692
|
|
Hepatitis - B
|
NCRR
|
5P51RR000169-47
|
5777
|
MEASLES VIRUSES WITH ADDED VACCINE SPECIFICITIES
|
CATTANEO, ROBERTO
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$80,482
|
|
Hepatitis - B
|
NIA
|
5P51RR000169-47
|
5777
|
MEASLES VIRUSES WITH ADDED VACCINE SPECIFICITIES
|
CATTANEO, ROBERTO
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$851
|
|
Hepatitis - B
|
NCRR
|
5P51RR013986-10
|
6269
|
BOOSTING HBV RESPONSES IN BABOONS
|
RICE, KAREN
|
SOUTHWEST FOUNDATION FOR BIOMEDICAL RES
|
TX
|
$127
|
|
Hepatitis - B
|
NCRR
|
5P51RR013986-10
|
6283
|
HBV RESOLUTION IN CHIMPANZEES
|
LANFORD, ROBERT
|
SOUTHWEST FOUNDATION FOR BIOMEDICAL RES
|
TX
|
$9,136
|
|
Hepatitis - B
|
NCRR
|
5M01RR000065-46
|
7134
|
DATABASE ON PTS WHO RECEIVE ORTHOTOPIC LIVER TRANSPLANTATION FOR HEP B
|
LUKETIC, VELIMIR
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$5,689
|
|
Hepatitis - B
|
NCRR
|
5M01RR020359-04
|
7289
|
ATN 025: HEPATITIS B VACCINATION IN YOUTHS
|
D'ANGELO, LAWRENCE
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$32,283
|
|
Hepatitis - B
|
NCRR
|
5M01RR020359-04
|
7290
|
ATN 024: A RANDOMIZED, OPEN-LABEL TRIAL OF THREE HEPATITIS B VACCINATION
|
D'ANGELO, LAWRENCE
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$28,240
|
|
Hepatitis - B
|
NCRR
|
5M01RR020359-04
|
7317
|
ATN 048: CORRELATES OF HBV-SPECIFIC B CELL MEMORY FOLLOWING VACCINATION IN HIV
|
D'ANGELO, LAWRENCE
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$4,031
|
|
Hepatitis - B
|
NCRR
|
5M01RR000071-45
|
8315
|
PROTECTIVE IMMUNITY TO HBV IN HIV+ PATIENTS WITH ISOLATED HBV CORE ANTIBODY
|
FISHBEIN, DAWN
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$70,640
|
|
Hepatitis - B
|
NCRR
|
5M01RR000096-47
|
8561
|
CLINICAL TRIAL: ACTG A5220: USING GM-CSF TO IMPROVE IMMUNE RESPONSE TO HEPATITIS
|
ABERG, JUDITH
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$63,698
|
|
Hepatitis - B
|
NCRR
|
5P20RR020185-05
|
7153
|
VIRUSES: FROM PARTICLES TO PROTEOMICS
|
BOTHNER, BRIAN
|
MONTANA STATE UNIVERSITY (BOZEMAN)
|
MT
|
$128,541
|
|
Hepatitis - B
|
NCRR
|
5P41RR010888-12
|
5187
|
REVERSE TRANSCRIPTION-ASSOCIATED DEPHOSPHORYLATION OF HEPADNAVIRUS NUCLEOCAPSID
|
HU, JIANMING
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$12,961
|
|
Hepatitis - B
|
NCRR
|
5M01RR000827-33
|
7093
|
GENERAL CLINICAL RESEARCH CENTER RESEARCH BLOOD PROGRAM
|
COOPER, DAN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$158,450
|
|
Hepatitis - B
|
NIAID
|
1Z01AI000999-02
|
|
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
|
FARCI, PATRIZIA
|
NIH
|
|
$603,252
|
|
Hepatitis - B
|
NIAID
|
1Z01AI001015-02
|
|
Pathogenesis of Parenteral Viral Hepatitis
|
PURCELL, ROBERT
|
NIH
|
|
$684,996
|
|
Hepatitis - B
|
NIAID
|
1Z01AI005083-04
|
|
Structure and Immunogenicity of HIV-1 gp41 Membrane Proximal Region (MPR)
|
WYATT, RICHARD
|
NIH
|
|
$469,750
|
|
Hepatitis - B
|
NIAMS
|
1Z01AR027002-30
|
|
Structural Biology Of Virus Assembly
|
STEVEN, ALASDAIR
|
NIH
|
|
$1,030,437
|
|
Hepatitis - B
|
NIAMS
|
1Z01AR041117-13
|
|
Structure And Assembly Of The Hepatitis B Nucleocapsid Protein
|
WINGFIELD, PAUL
|
NIH
|
|
$655,527
|
|
Hepatitis - B
|
NCI
|
1Z01BC005793-14
|
|
Mechanism of viral hepatitis-mediated hepatocarcinogenesis
|
WANG, XIN
|
NIH
|
|
$326,950
|
|
Hepatitis - B
|
NCI
|
1Z01BC010271-12
|
|
Identification of Genes Involved in HIV-1AIDS, HBV and HCV
|
SMITH, MICHAEL
|
NIH
|
|
$287,309
|
|
Hepatitis - B
|
NCI
|
1Z01BC010798-02
|
|
Genetic Investigation of NPC and HCC in a Chinese Population
|
WINKLER, CHERYL
|
NIH
|
|
$123,250
|
|
Hepatitis - B
|
NCI
|
1Z01CP010139-11
|
|
Molecular Genetic Epidemiology of Primary Hepatocellular Carcinoma
|
BUETOW, KENNETH
|
NIH
|
|
$1,576,967
|
|
Hepatitis - B
|
NCI
|
1Z01CP010158-08
|
|
Studies of Rare Cancers
|
BRINTON, LOUISE
|
NIH
|
|
$983,415
|
|
Hepatitis - B
|
NIDDK
|
1Z01DK054500-12
|
|
Molecular Mechanisms Of Hepatitis B Viral Pathogenesis And Persistence
|
LIANG, T. JAKE
|
NIH
|
|
$466,145
|
|
Hepatitis - B
|
NIDDK
|
1Z01DK054501-12
|
|
Clinical Significance And Molecular Pathogenesis Of Hepatitis B Virus Mutants
|
LIANG, T. JAKE
|
NIH
|
|
$466,145
|
|
Hepatitis - B
|
NIDDK
|
1Z01DK054517-02
|
|
Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis B
|
GHANY, MARC
|
NIH
|
|
$567,141
|
